Literature DB >> 11607846

The NOD: a signaling module that regulates apoptosis and host defense against pathogens.

N Inohara1, G Nuñez.   

Abstract

Nods, a growing family of proteins containing a nucleotide-binding oligomerization domain (NOD), are involved in the regulation of programmed cell death (PCD) and immune responses. Members of the family include Apaf-1, Ced-4, Nod1, Nod2, and the cytosolic products of plant disease resistance genes. The NOD module is homologous to the ATP-binding cassette (ABC) found in a large number of proteins with diverse biological function. The centrally located NOD promotes activation of effector molecules through self-association and induced proximity of binding partners. The C-terminal domain of Nods serves as a sensor for intracellular ligands, whereas the N-terminal domain mediates binding to dowstream effector molecules and activation of diverse signaling pathways. Thus, Nods activate, through the NOD module, diverse signaling pathways involved in the elimination of cells via PCD and the host defense against pathogens.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11607846     DOI: 10.1038/sj.onc.1204787

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  68 in total

1.  Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever.

Authors:  H M Hoffman; A A Wanderer; D H Broide
Journal:  J Allergy Clin Immunol       Date:  2001-10       Impact factor: 10.793

2.  Inflammatory Bowel Disease: Future Therapies.

Authors:  Sander J.H. Van Deventer
Journal:  Curr Treat Options Gastroenterol       Date:  2002-06

3.  Interaction between domains of a plant NBS-LRR protein in disease resistance-related cell death.

Authors:  Peter Moffett; Garry Farnham; Jack Peart; David C Baulcombe
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

4.  Crohn's disease risk alleles on the NOD2 locus have been maintained by natural selection on standing variation.

Authors:  Shigeki Nakagome; Shuhei Mano; Lukasz Kozlowski; Janusz M Bujnicki; Hiroki Shibata; Yasuaki Fukumaki; Judith R Kidd; Kenneth K Kidd; Shoji Kawamura; Hiroki Oota
Journal:  Mol Biol Evol       Date:  2012-01-12       Impact factor: 16.240

Review 5.  Molecular pathogenesis of infections caused by Legionella pneumophila.

Authors:  Hayley J Newton; Desmond K Y Ang; Ian R van Driel; Elizabeth L Hartland
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

Review 6.  Forward genetic dissection of innate response to infection in inbred mouse strains: selected success stories.

Authors:  S Gruenheid; P Gros
Journal:  Clin Exp Immunol       Date:  2010-12       Impact factor: 4.330

Review 7.  Emerging significance of NLRs in inflammatory bowel disease.

Authors:  Beckley K Davis; Casandra Philipson; Raquel Hontecillas; Kristin Eden; Josep Bassaganya-Riera; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

8.  Indirect activation of a plant nucleotide binding site-leucine-rich repeat protein by a bacterial protease.

Authors:  Jules Ade; Brody J DeYoung; Catherine Golstein; Roger W Innes
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-02       Impact factor: 11.205

9.  L-Ala-γ-D-Glu-meso-diaminopimelic acid (DAP) interacts directly with leucine-rich region domain of nucleotide-binding oligomerization domain 1, increasing phosphorylation activity of receptor-interacting serine/threonine-protein kinase 2 and its interaction with nucleotide-binding oligomerization domain 1.

Authors:  Hamed Laroui; Yutao Yan; Yoshie Narui; Sarah A Ingersoll; Saravanan Ayyadurai; Moiz A Charania; Feimeng Zhou; Binghe Wang; Khalid Salaita; Shanthi V Sitaraman; Didier Merlin
Journal:  J Biol Chem       Date:  2011-07-12       Impact factor: 5.157

Review 10.  NLR proteins: integral members of innate immunity and mediators of inflammatory diseases.

Authors:  Jeanette M Wilmanski; Tanja Petnicki-Ocwieja; Koichi S Kobayashi
Journal:  J Leukoc Biol       Date:  2007-09-17       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.